ClinVar Miner

Submissions for variant NM_000038.6(APC):c.6526T>C (p.Leu2176=)

gnomAD frequency: 0.00023  dbSNP: rs183468041
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 14
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000211925 SCV000209479 benign not specified 2014-07-02 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Ambry Genetics RCV000159522 SCV000213601 likely benign Hereditary cancer-predisposing syndrome 2014-09-09 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Invitae RCV003650404 SCV000252934 benign Familial adenomatous polyposis 1 2024-01-31 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000282259 SCV000452037 uncertain significance APC-Associated Polyposis Disorders 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000211925 SCV000600130 benign not specified 2017-07-13 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000159522 SCV000681806 likely benign Hereditary cancer-predisposing syndrome 2016-06-16 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000587270 SCV000694098 benign not provided 2016-05-09 criteria provided, single submitter clinical testing Variant summary: The APC c.6526T>C (p.Leu2176Leu) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. Mutation taster predicts a damaging outcome for this variant. This variant was found in 24/119852 control chromosomes, predominantly observed in the Latino subpopulation at a frequency of 0.0005199 (6/11540). This frequency is about 9 times the estimated maximal expected allele frequency of a pathogenic APC variant (0.0000602), suggesting this is likely a benign polymorphism found primarily in the populations of Latino origin. The variant of interest has not, to our knowledge, been reported in affected individuals via publications nor evaluated for functional impact by in vivo/vitro studies. Clinical diagnostic laboratories classified this variant as Benign/Likely Benign. Taken together, this variant is classified as Benign.
PreventionGenetics, part of Exact Sciences RCV000587270 SCV000805456 likely benign not provided 2016-07-08 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000587270 SCV001154475 likely benign not provided 2024-02-01 criteria provided, single submitter clinical testing APC: BP4, BP7
Sema4, Sema4 RCV000159522 SCV002528785 likely benign Hereditary cancer-predisposing syndrome 2021-06-17 criteria provided, single submitter curation
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital RCV000211925 SCV002550645 likely benign not specified 2023-08-15 criteria provided, single submitter clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV001356057 SCV001551115 likely benign Carcinoma of colon no assertion criteria provided clinical testing The APC p.Leu2176= variant was not identified in the literature nor was it identified in the GeneInsight, Cosmic, UMD and Zhejiang Colon Cancer databases. The variant was identified in dbSNP (ID: rs183468041) “With unknown allele”, with a minor allele frequency of 0.0002 (1 of 5000 chromosomes in 1000 Genomes Project). In the NHLBI Exome Sequencing Project (Exome Variant Server), the variant was identified in 1 of 8590 European American chromosomes and was not found in 4390 African American chromosomes. In Exome Aggregation Consortium (ExAC) database, the variant was identified in 17 of 6605 European (Non-Finnish), 6 of 11540 Latinos and 1 of 9654 Africans, increasing the likelihood this could be a low frequency benign variant in certain populations of origin. The variant was identified in Clinvitae (1x as variant of unknown significance), LOVD (1x as no known pathogenicity) and InSiGHT Colon Cancer Database. In the ClinVar database the variant was reported as benign by GeneDX and as likely benign by Ambry Genetics. The p.Leu2176= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign.
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV000587270 SCV001809234 likely benign not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000587270 SCV001951870 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.